RF-power and temperature data analysis of 444 patients with primary cervical cancer: deep hyperthermia using the Sigma-60 applicator is reproducible
/in Cervical Cancer, International Publications /von 2007-12-01 / Int J Hyperthermia 2007 Dec;23(8):623-43Characteristics of hybrid cells obtained by dendritic cell/tumour cell fusion in a T-47D breast cancer cell line model indicate their potential as anti-tumour vaccines
/in Breast Cancer, International Publications /von 2007-12-01 / Int. J. Oncol. 2007 Dec;31(6):1357-65Experimental evidence for the efficacy of combined therapy of CPT-11 and hyperthermia for squamous cell carcinoma of the esophagus
/in Esophageal Carcinoma, Hyperthermia, International Publications /von 2007-12-01 / Hepatogastroenterology 2007 Dec;54(80):2272-5Advances in specific immunotherapy for prostate cancer
/in International Publications, Prostate Cancer /von 2007-11-26 / Eur. Urol. 2008 Apr;53(4):694-708Dendritic cells loaded with apoptotic antibody-coated tumor cells provide protective immunity against B-cell lymphoma in vivo
/in International Publications, Malignant Lymphoma /von 2007-11-09 / Blood 2008 Feb;111(3):1504-11Hyperthermia induces endoplasmic reticulum-mediated apoptosis in melanoma and non-melanoma skin cancer cells
/in Hyperthermia, International Publications, Malignant Melanoma /von 2007-11-08 / J. Invest. Dermatol. 2008 Apr;128(4):949-56[The anti-tumor efforts of thymosin alpha1 on tumor lysate-pulsed dendritic cells in colon cancer in vitro and in vivo]
/in Colorectal Cancer, International Publications /von 2007-11-01 / Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2007 Nov;23(11):1046-9Antitumor effect of whole body hyperthermia with alpha-galactosylceramide in a subcutaneous tumor model of colon cancer
/in Colorectal Cancer, Hyperthermia, International Publications /von 2007-11-01 / Int J Hyperthermia 2007 Nov;23(7):591-8[Effects of intratumoral injection therapy of dendritic cells combined with hyperthermia for cancer patients]
/in Dendritic Cells, International Publications /von 2007-11-01 / Gan To Kagaku Ryoho 2007 Nov;34(12):1905-7
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de